JP2025098147A5 - - Google Patents
Info
- Publication number
- JP2025098147A5 JP2025098147A5 JP2025049941A JP2025049941A JP2025098147A5 JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5 JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fat
- ligand
- composition according
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL264112 | 2019-01-06 | ||
| IL264112A IL264112A (en) | 2019-01-06 | 2019-01-06 | An a3 adenosine receptor ligand for use for reducing level of adipocytes |
| JP2021539140A JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023078136A Division JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025098147A JP2025098147A (ja) | 2025-07-01 |
| JP2025098147A5 true JP2025098147A5 (https=) | 2026-04-06 |
Family
ID=65656120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2025049941A Pending JP2025098147A (ja) | 2019-01-06 | 2025-03-25 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12213990B2 (https=) |
| EP (1) | EP3906034A1 (https=) |
| JP (3) | JP2022517753A (https=) |
| KR (1) | KR20210113279A (https=) |
| CN (1) | CN113543790A (https=) |
| AU (1) | AU2020205042B2 (https=) |
| BR (1) | BR112021013084A2 (https=) |
| CA (1) | CA3126002A1 (https=) |
| IL (2) | IL264112A (https=) |
| MX (1) | MX2021008172A (https=) |
| WO (1) | WO2020141535A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202300014340A1 (it) * | 2023-07-10 | 2025-01-10 | Consiglio Nazionale Ricerche | Trattamento di malattie associate alla disfunzione del gene ocrl. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443836A (en) | 1993-03-15 | 1995-08-22 | Gensia, Inc. | Methods for protecting tissues and organs from ischemic damage |
| US5688774A (en) | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| DE69428536T2 (de) | 1993-07-13 | 2002-06-06 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | A3 -adenosin -rezeptor agonisten |
| AU1399297A (en) | 1996-01-24 | 1997-08-20 | Sumitomo Chemical Company, Limited | Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production |
| US6048865A (en) | 1997-07-29 | 2000-04-11 | Medco Research, Inc. | N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator |
| AU8764398A (en) | 1997-07-29 | 1999-02-22 | Medco Research, Inc. | N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| WO1999020284A1 (en) | 1997-10-23 | 1999-04-29 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| CN101410114B (zh) | 2006-01-26 | 2012-07-04 | 美国政府卫生与公共服务部 | A3腺苷受体别构调节剂 |
| EP2608794A4 (en) * | 2010-08-26 | 2014-01-22 | Univ Northeastern | METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING OIL CONTAINER |
| CN104159589A (zh) | 2012-01-23 | 2014-11-19 | 坎-菲特生物药物有限公司 | 肝脏状况的治疗 |
| IL242723B (en) * | 2015-11-23 | 2019-12-31 | Can Fite Biopharma Ltd | A3 adenosine receptor ligand for the treatment of ectopic fat accumulation |
| KR101881441B1 (ko) | 2017-01-20 | 2018-07-24 | 서울대학교산학협력단 | 다중 약리단 특성에 기반한 비정상적 아디포넥틴 관련 질환 치료용 조성물 |
-
2019
- 2019-01-06 IL IL264112A patent/IL264112A/en unknown
-
2020
- 2020-01-05 BR BR112021013084-5A patent/BR112021013084A2/pt unknown
- 2020-01-05 CA CA3126002A patent/CA3126002A1/en active Pending
- 2020-01-05 JP JP2021539140A patent/JP2022517753A/ja active Pending
- 2020-01-05 MX MX2021008172A patent/MX2021008172A/es unknown
- 2020-01-05 AU AU2020205042A patent/AU2020205042B2/en active Active
- 2020-01-05 US US17/309,952 patent/US12213990B2/en active Active
- 2020-01-05 CN CN202080008167.6A patent/CN113543790A/zh active Pending
- 2020-01-05 WO PCT/IL2020/050011 patent/WO2020141535A1/en not_active Ceased
- 2020-01-05 EP EP20700855.8A patent/EP3906034A1/en active Pending
- 2020-01-05 IL IL284463A patent/IL284463B1/en unknown
- 2020-01-05 KR KR1020217024682A patent/KR20210113279A/ko active Pending
-
2023
- 2023-05-10 JP JP2023078136A patent/JP2023100928A/ja active Pending
-
2025
- 2025-03-25 JP JP2025049941A patent/JP2025098147A/ja active Pending